BASIC FACTS
DATE OF LAUNCH
4 JUL 2004
CATEGORY
EQUITY
TYPE
MID CAP
AUM*
Rs.7,348 crore
BENCHMARK
NIFTY MIDCAP 150
TOTAL RETURN INDEX
WHAT IT COSTS
NAV**
GROWTH OPTION
Rs.194.84
IDCW
Rs.92.20
MINIMUM INVESTMENT
Rs.5,000
MINIMUM SIP AMOUNT
Rs.500
EXPENSE RATIO*** (%)
1.78
EXIT LOAD
1% for redemption
inside 364 days
*AS ON 31 OCTOBER 2022
**AS ON 6 DECEMBER 2022
***AS ON 31 OCTOBER 2022
FUND MANAGER
ANKIT AGARWAL
TENURE: 3 YEARS, 3 MONTHS
Recent portfolio adjustments
New Entrants: Aarti Pharmalabs, The Ramco Cements.
Complete Exits: NA
Increasing allocation: Bharat Electronics, Dr. Lal Pathlabs, Jubilant FoodWorks, PB Fintech, Sundram Fasteners, Syngene International, United Breweries (Sept), Alkem Labs, Balkrishna Inds, Dr. Lal Pathlabs, Honeywell Automation, PB Fintech, Prestige Estates, Sundram Fasteners, United Breweries (Oct)
Should you purchase?
This mid cap fund runs a mix of progress and worth investing fashion with a tilt in the direction of progress. Its desire is for companies with scalable fashions with lengthy progress runway however stays open for firms going by transitory section of weak point or transformational change. The portfolio is closely diversified with modest positions even in prime bets. It is sector agnostic and retains flexibility to keep invested in shares rising into giant caps. The fund’s efficiency has slipped visibly in recent times. While it retains a wholesome risk-return profile, it should plug the gap with index and friends shortly to stay a superb decide.
(Source: Value Research)
.
